Comparison of VTD (velcade-thalidomide-dexamethasone) and a conventional chemotherapy induction regimen: effect on stem cell mobilization and engraftment of ASCT (autologous stem cell transplantation) for newly diagnosed multiple myeloma

被引：0

作者：

Requena, M. J. ^{[1
]}

Yebra, E. ^{[1
]}

Berberana, M. ^{[1
]}

Payamps, C. ^{[1
]}

Diaz Goizueta, M. ^{[1
]}

Riaza, R. ^{[1
]}

Penalver, M. A. ^{[1
]}

Rodriguez, R. ^{[1
]}

Sanchez Godoy, P. ^{[1
]}

机构：

[1] Hosp Severo Ochoa, Madrid, Spain

来源：

BONE MARROW TRANSPLANTATION | 2013年 / 48卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S212 / S213

页数：2

共 50 条

[31] Stem Cell Mobilization Capacity Is Not a Predictor of Survival in Multiple Myeloma (MM) After Autologous Stem Cell Transplantation (ASCT)
Lim, Gloria
Xu, Wei
Young, Trieu
Winter, Andrew
Reece, Donna E.
Trudel, Suzanne
Kukreti, Vishal
Anglin, Peter
Chen, Christine
BLOOD, 2009, 114 (22) : 847 - 847
[32] A comparison of mobilization regimens in autologous stem cell transplantation for multiple myeloma
Chandler, T.
Seymour, F.
Parrish, C.
Karakantza, M.
Pawson, D.
Carmichael, J.
Cook, G.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 408 - 408
[33] Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma
Poenisch, Wolfram
Ploetze, Madlen
Holzvogt, Bruno
Andrea, Marc
Schliwa, Thomas
Zehrfeld, Thomas
Hammerschmidt, Doreen
Schwarz, Maik
Edelmann, Thomas
Becker, Cornelia
Hoffmann, Franz Albert
Schwarzer, Andreas
Kreibich, Ute
Gutsche, Kerstin
Reifenrath, Kolja
Schwarzbach, Heidrun
Heyn, Simone
Franke, Georg-Nikolaus
Jentzsch, Madlen
Leiblein, Sabine
Schwind, Sebastian
Lange, Thoralf
Vucinic, Vladan
Alali, Haifa-Katrin
Niederwieser, Dietger
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (11) : 2013 - 2022
[34] Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma
Wolfram Poenisch
Madlen Plötze
Bruno Holzvogt
Marc Andrea
Thomas Schliwa
Thomas Zehrfeld
Doreen Hammerschmidt
Maik Schwarz
Thomas Edelmann
Cornelia Becker
Franz Albert Hoffmann
Andreas Schwarzer
Ute Kreibich
Kerstin Gutsche
Kolja Reifenrath
Heidrun Schwarzbach
Simone Heyn
Georg-Nikolaus Franke
Madlen Jentzsch
Sabine Leiblein
Sebastian Schwind
Thoralf Lange
Vladan Vucinic
Haifa-Katrin AlAli
Dietger Niederwieser
Journal of Cancer Research and Clinical Oncology, 2015, 141 : 2013 - 2022
[35] Thalidomide/Dexamethasone (TD) Vs. Bortezomib(Velcade®)/Thalidomide/Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcade® As Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Younger Patients with Multiple Myeloma (MM): First Results of a Prospective Phase III PETHEMA/Gem Trial
Rosinol, Laura
Teresa Cibeira, M.
Martinez, Joaquin
Victoria Mateos, Maria
Jose Terol, M.
de la Rubia, Javier
Palomera, Luis
de Arriba, Felipe
Oriol, Albert
Alegre, Adrian
Besalduch, Juan
de Paz, Raquel
Garcia-Larana, Jose
Diaz-Mediavilla, Joaquin
Sureda, Anna
Jose Lahuerta, Juan
Miguel, J. F. San
Blade, Joan
BLOOD, 2008, 112 (11) : 244 - 244
[36] STEM CELL MOBILIZATION AND AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER INDUCTION WITH BENDAMUSTINE, PREDNISONE AND BORTEZOMIB (BPV) IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH RENAL IMPAIRMENT
Fricke, Susann
Poenisch, Wolfram
Holzhey, Tanja
Holzvogt, Madlen
Andrea, Marc
Vucinic, Vladan
Franke, Georg-Nikolaus
Heyn, Simone
Hell, Saskia
Schetschorke, Birthe
Jentzsch, Madlen
Schwind, Sebastian
Zehrfeld, Thomas
Braunert, Leanthe
Edelmann, Thomas
Becker, Cornelia
Hoffmann, Franz-Albert
Reifenrath, Kolja
Schwarz, Maik
Schwarzer, Andreas
Flade, Franziska
Hammerschmidt, Dorren
Scholz, Markus
Platzbecker, Uwe
Merz, Maximilian
Wang, Song-Yau
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 490 - 490
[37] Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
Cavo, Michele
Pantani, Lucia
Petrucci, Maria Teresa
Patriarca, Francesca
Zamagni, Elena
Donnarumma, Daniela
Crippa, Claudia
Boccadoro, Mario
Perrone, Giulia
Falcone, Antonietta
Nozzoli, Chiara
Zambello, Renato
Masini, Luciano
Furlan, Anna
Brioli, Annamaria
Derudas, Daniele
Ballanti, Stelvio
Dessanti, Maria Laura
De Stefano, Valerio
Carella, Angelo Michele
Marcatti, Magda
Nozza, Andrea
Ferrara, Felicetto
Callea, Vincenzo
Califano, Catello
Pezzi, Annalisa
Baraldi, Anna
Grasso, Mariella
Musto, Pellegrino
Palumbo, Antonio
BLOOD, 2012, 120 (01) : 9 - 19
[38] COST-EFFECTIVENESS OF INDUCTION TREATMENT WITH BORTEZOMIB ADDED TO THALIDOMIDE AND DEXAMETHASONE IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN GERMANY
van Beurden-Tan, C.
Rosinol, L.
Diels, J.
Wirth, D.
Chirita, O.
Lahuerta, J. J.
Gaugris, S.
Marsh, S.
San Miguel, J.
Spencer, M.
Treur, M.
Blade, J.
VALUE IN HEALTH, 2013, 16 (07) : A409 - A410
[39] Autologous stem cell transplantation (ASCT) followed by consolidation chemotherapy for multiple myeloma (MM).
Gojo, I
Murthy, A
Fassas, A
Tricot, G
Fenton, R
Mookerjee, B
Meisenberg, B
Takebe, N
Frankel, SR
Sarkodee-Adoo, C
Heyman, MR
Ruehle, K
Smith, R
Chen, T
Rapoport, A
BLOOD, 2000, 96 (11) : 369B - 369B
[40] Autologous stem cell transplantation (ASCT) followed by consolidation chemotherapy for multiple myeloma (MM).
Murthy, A
Gojo, I
Fassas, A
Tricot, G
Fenton, R
Mookerjee, B
Meisenberg, B
Takebe, N
Lipani, T
Badros, A
Phillips, G
Sarkodee-Adoo, C
Heyman, M
Ruehle, K
Smith, R
Guo, CF
Rapoport, A
BLOOD, 2001, 98 (11) : 685A - 685A

← 1 2 3 4 5 →